

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA strand elongation involved in DNA replication (GO:0006271) | 5.01994417 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.99572891 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.99572891 |
| 4 | DNA strand elongation (GO:0022616) | 4.90623532 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.85504943 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.85504943 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.85504943 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.85504943 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.85504943 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.85504943 |
| 11 | DNA deamination (GO:0045006) | 4.81054531 |
| 12 | ribosomal small subunit assembly (GO:0000028) | 4.76330908 |
| 13 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.72334516 |
| 14 | DNA unwinding involved in DNA replication (GO:0006268) | 4.43906004 |
| 15 | DNA replication initiation (GO:0006270) | 4.42959252 |
| 16 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.35740819 |
| 17 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.25458387 |
| 18 | modulation by virus of host process (GO:0019054) | 4.24613458 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.19719893 |
| 20 | nucleobase biosynthetic process (GO:0046112) | 4.03442289 |
| 21 | purine nucleobase biosynthetic process (GO:0009113) | 3.99698153 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.98929032 |
| 23 | telomere maintenance via recombination (GO:0000722) | 3.91979959 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.88662126 |
| 25 | GDP-mannose metabolic process (GO:0019673) | 3.84300280 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.82380525 |
| 27 | mannose metabolic process (GO:0006013) | 3.78460471 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.78417643 |
| 29 | DNA replication checkpoint (GO:0000076) | 3.77737402 |
| 30 | neutrophil activation involved in immune response (GO:0002283) | 3.74655223 |
| 31 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.73163120 |
| 32 | histone H4 deacetylation (GO:0070933) | 3.68701674 |
| 33 | modulation by symbiont of host cellular process (GO:0044068) | 3.64045136 |
| 34 | snRNA processing (GO:0016180) | 3.62765168 |
| 35 | telomere maintenance via telomere lengthening (GO:0010833) | 3.61668110 |
| 36 | mitotic recombination (GO:0006312) | 3.58758348 |
| 37 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.55041117 |
| 38 | response to peptidoglycan (GO:0032494) | 3.50777497 |
| 39 | IMP biosynthetic process (GO:0006188) | 3.49250414 |
| 40 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.48826875 |
| 41 | binding of sperm to zona pellucida (GO:0007339) | 3.47527245 |
| 42 | oxygen transport (GO:0015671) | 3.47008809 |
| 43 | sperm-egg recognition (GO:0035036) | 3.44662240 |
| 44 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.43812347 |
| 45 | detection of bacterium (GO:0016045) | 3.41016822 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 3.37994702 |
| 47 | cellular response to virus (GO:0098586) | 3.37475858 |
| 48 | snRNA metabolic process (GO:0016073) | 3.36821972 |
| 49 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.33650288 |
| 50 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.33650288 |
| 51 | regulation of spindle checkpoint (GO:0090231) | 3.33592424 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.31514693 |
| 53 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.31318418 |
| 54 | NIK/NF-kappaB signaling (GO:0038061) | 3.31019785 |
| 55 | response to host immune response (GO:0052572) | 3.29741070 |
| 56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29741070 |
| 57 | CENP-A containing nucleosome assembly (GO:0034080) | 3.29445913 |
| 58 | IMP metabolic process (GO:0046040) | 3.29266015 |
| 59 | chromatin remodeling at centromere (GO:0031055) | 3.26746059 |
| 60 | viral mRNA export from host cell nucleus (GO:0046784) | 3.25367684 |
| 61 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.23436300 |
| 62 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.22727177 |
| 63 | protein localization to chromosome, centromeric region (GO:0071459) | 3.22463535 |
| 64 | viral protein processing (GO:0019082) | 3.22219120 |
| 65 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.21457436 |
| 66 | formation of translation preinitiation complex (GO:0001731) | 3.20218424 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 3.19491621 |
| 68 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.19405409 |
| 69 | detection of other organism (GO:0098543) | 3.18641414 |
| 70 | maturation of SSU-rRNA (GO:0030490) | 3.17731603 |
| 71 | leukocyte aggregation (GO:0070486) | 3.17045972 |
| 72 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.08983075 |
| 73 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.08983075 |
| 74 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.08131099 |
| 75 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.06614117 |
| 76 | DNA replication-independent nucleosome organization (GO:0034724) | 3.06614117 |
| 77 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.06058124 |
| 78 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.05752215 |
| 79 | ribosome biogenesis (GO:0042254) | 3.05077310 |
| 80 | cell-cell recognition (GO:0009988) | 3.05073731 |
| 81 | regulation of chromatin binding (GO:0035561) | 3.04416900 |
| 82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.04233834 |
| 83 | neutrophil activation (GO:0042119) | 3.04123373 |
| 84 | histone exchange (GO:0043486) | 3.03307378 |
| 85 | histone H3 deacetylation (GO:0070932) | 3.02605551 |
| 86 | mitotic nuclear envelope disassembly (GO:0007077) | 3.02459186 |
| 87 | tolerance induction (GO:0002507) | 3.00227855 |
| 88 | heme biosynthetic process (GO:0006783) | 2.99330485 |
| 89 | regulation of leukocyte degranulation (GO:0043300) | 2.98560319 |
| 90 | protein localization to kinetochore (GO:0034501) | 2.95518761 |
| 91 | response to host (GO:0075136) | 2.94953740 |
| 92 | response to host defenses (GO:0052200) | 2.94953740 |
| 93 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.94953740 |
| 94 | negative regulation of innate immune response (GO:0045824) | 2.94341775 |
| 95 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91838808 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91618104 |
| 97 | response to muramyl dipeptide (GO:0032495) | 2.90921441 |
| 98 | positive regulation of granulocyte differentiation (GO:0030854) | 2.89356544 |
| 99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.87585198 |
| 100 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.85200343 |
| 101 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.84619693 |
| 102 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.82741733 |
| 103 | termination of RNA polymerase III transcription (GO:0006386) | 2.82741733 |
| 104 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.82546593 |
| 105 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.82546593 |
| 106 | kinetochore organization (GO:0051383) | 2.81373195 |
| 107 | regulation of necroptotic process (GO:0060544) | 2.80029444 |
| 108 | cardiolipin metabolic process (GO:0032048) | 2.79524583 |
| 109 | kinetochore assembly (GO:0051382) | 2.79142802 |
| 110 | negative regulation of interleukin-12 production (GO:0032695) | 2.78633176 |
| 111 | telomere organization (GO:0032200) | 2.78069024 |
| 112 | intra-S DNA damage checkpoint (GO:0031573) | 2.77923092 |
| 113 | granulocyte activation (GO:0036230) | 2.77887452 |
| 114 | telomere maintenance (GO:0000723) | 2.77838533 |
| 115 | mitotic sister chromatid segregation (GO:0000070) | 2.77477360 |
| 116 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.77129561 |
| 117 | regulation of granulocyte differentiation (GO:0030852) | 2.77044795 |
| 118 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76418029 |
| 119 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76255133 |
| 120 | chromosome condensation (GO:0030261) | 2.74699012 |
| 121 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.74529277 |
| 122 | histone H3-K36 demethylation (GO:0070544) | 2.73874321 |
| 123 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.73458738 |
| 124 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.72982184 |
| 125 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.72701463 |
| 126 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.72478248 |
| 127 | sperm motility (GO:0030317) | 2.72218674 |
| 128 | positive thymic T cell selection (GO:0045059) | 2.71132817 |
| 129 | translational elongation (GO:0006414) | 2.70884719 |
| 130 | rRNA transcription (GO:0009303) | 2.70453315 |
| 131 | membrane disassembly (GO:0030397) | 2.69807688 |
| 132 | nuclear envelope disassembly (GO:0051081) | 2.69807688 |
| 133 | microtubule depolymerization (GO:0007019) | 2.68669809 |
| 134 | erythrocyte development (GO:0048821) | 2.68005349 |
| 135 | base-excision repair (GO:0006284) | 2.67637295 |
| 136 | negative regulation of necroptotic process (GO:0060546) | 2.67386754 |
| 137 | spermatid development (GO:0007286) | 2.66870998 |
| 138 | * DNA replication (GO:0006260) | 2.66481274 |
| 139 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.66056834 |
| 140 | respiratory burst (GO:0045730) | 2.65385203 |
| 141 | negative regulation of myotube differentiation (GO:0010832) | 2.64425550 |
| 142 | negative regulation of phagocytosis (GO:0050765) | 2.64181851 |
| 143 | negative regulation of glial cell proliferation (GO:0060253) | 2.64017870 |
| 144 | pseudouridine synthesis (GO:0001522) | 2.63871956 |
| 145 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.63761014 |
| 146 | protein-DNA complex disassembly (GO:0032986) | 2.62981730 |
| 147 | nucleosome disassembly (GO:0006337) | 2.62981730 |
| 148 | erythrocyte maturation (GO:0043249) | 2.62300256 |
| 149 | replicative senescence (GO:0090399) | 2.62293245 |
| 150 | mitotic metaphase plate congression (GO:0007080) | 2.62057098 |
| 151 | histone H2A acetylation (GO:0043968) | 2.61998065 |
| 152 | spliceosomal snRNP assembly (GO:0000387) | 2.60981018 |
| 153 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.60158958 |
| 154 | interferon-gamma secretion (GO:0072643) | 2.59782339 |
| 155 | barbed-end actin filament capping (GO:0051016) | 2.59453037 |
| 156 | hemoglobin metabolic process (GO:0020027) | 2.59409359 |
| 157 | thymic T cell selection (GO:0045061) | 2.59208476 |
| 158 | DNA packaging (GO:0006323) | 2.59187172 |
| 159 | gas transport (GO:0015669) | 2.58990503 |
| 160 | myeloid cell activation involved in immune response (GO:0002275) | 2.58834724 |
| 161 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.58659464 |
| 162 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.58283390 |
| 163 | negative regulation of cell size (GO:0045792) | 2.58080502 |
| 164 | DNA-dependent DNA replication (GO:0006261) | 2.55677537 |
| 165 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.55329866 |
| 166 | pentose-phosphate shunt (GO:0006098) | 2.55024324 |
| 167 | leukocyte degranulation (GO:0043299) | 2.54851954 |
| 168 | viral transcription (GO:0019083) | 2.54559791 |
| 169 | virion assembly (GO:0019068) | 2.54559245 |
| 170 | regulation of cell cycle checkpoint (GO:1901976) | 2.54032003 |
| 171 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.53147879 |
| 172 | acrosome assembly (GO:0001675) | 2.53100130 |
| 173 | pentose metabolic process (GO:0019321) | 2.52510629 |
| 174 | mRNA cleavage (GO:0006379) | 2.51790077 |
| 175 | 7-methylguanosine mRNA capping (GO:0006370) | 2.51688438 |
| 176 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.51161023 |
| 177 | RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502) | 2.50856356 |
| 178 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.50401752 |
| 179 | positive regulation of mast cell activation (GO:0033005) | 2.49718782 |
| 180 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.49220630 |
| 181 | positive regulation of histone deacetylation (GO:0031065) | 2.48952455 |
| 182 | natural killer cell differentiation (GO:0001779) | 2.48902813 |
| 183 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.48686142 |
| 184 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.48666325 |
| 185 | mismatch repair (GO:0006298) | 2.48377368 |
| 186 | detection of external biotic stimulus (GO:0098581) | 2.48167496 |
| 187 | termination of RNA polymerase II transcription (GO:0006369) | 2.47837976 |
| 188 | cell wall macromolecule catabolic process (GO:0016998) | 2.46893083 |
| 189 | cell wall macromolecule metabolic process (GO:0044036) | 2.46893083 |
| 190 | sulfur amino acid catabolic process (GO:0000098) | 2.46840136 |
| 191 | positive regulation of protein deacetylation (GO:0090312) | 2.46721696 |
| 192 | histone H3-K9 modification (GO:0061647) | 2.46653392 |
| 193 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.46554330 |
| 194 | cell cycle G1/S phase transition (GO:0044843) | 2.46554330 |
| 195 | regulation of cilium movement (GO:0003352) | 2.46549164 |
| 196 | negative regulation of interleukin-6 production (GO:0032715) | 2.46119226 |
| 197 | sister chromatid segregation (GO:0000819) | 2.45883736 |
| 198 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.45337741 |
| 199 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45200870 |
| 200 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.44585152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.70768198 |
| 2 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.74269272 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.47878697 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.35239775 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.27989670 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.21052357 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.08683323 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.03212666 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.98746834 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.87698652 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.86205652 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.81077084 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.78578457 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.68572005 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.67118701 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.65151758 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.51197039 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.43759207 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.39073615 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.37382051 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.30907955 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.26293054 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.21106625 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.17487939 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.15693995 |
| 26 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.13301900 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.12825946 |
| 28 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.11023591 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 2.09800340 |
| 30 | * P68_20966046_ChIP-Seq_HELA_Human | 2.09114087 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07966403 |
| 32 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05955664 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 2.03394121 |
| 34 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.01444316 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.01063945 |
| 36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.95758183 |
| 37 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.91514676 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.89677850 |
| 39 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.88174978 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.87424713 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83606945 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83071199 |
| 43 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.82407679 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.79854952 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.79376292 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.78849138 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.77999103 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77669889 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.77620609 |
| 50 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76651124 |
| 51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.76540519 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76290095 |
| 53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.76285860 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.74815046 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73765361 |
| 56 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.71982567 |
| 57 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.71921226 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.71006920 |
| 59 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.70572087 |
| 60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.68885182 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65863345 |
| 62 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65471674 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.65367119 |
| 64 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.65323341 |
| 65 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.63839824 |
| 66 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.62604814 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61637709 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59201190 |
| 69 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57182166 |
| 70 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.56706369 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.53801633 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.51689466 |
| 73 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.50944342 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50461576 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48212300 |
| 76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.46851350 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45376240 |
| 78 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.42092583 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41852606 |
| 80 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41727746 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37387818 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.34537185 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.34298653 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34172501 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.32920307 |
| 86 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.32513027 |
| 87 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.31044488 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.30954684 |
| 89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30871275 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30632465 |
| 91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.29922080 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29524038 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29164153 |
| 94 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28665139 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28559563 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 1.28522384 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28151063 |
| 98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27438875 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.26839725 |
| 100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26605403 |
| 101 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26590899 |
| 102 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.25579522 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24691672 |
| 104 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23740011 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23731617 |
| 106 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22028471 |
| 107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.21155609 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20634451 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.19046906 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18329366 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16797589 |
| 112 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16560321 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16487774 |
| 114 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15514553 |
| 115 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15485256 |
| 116 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14405800 |
| 117 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14239287 |
| 118 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14129817 |
| 119 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.13842553 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13812744 |
| 121 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12904778 |
| 122 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12565022 |
| 123 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.11327781 |
| 124 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10843963 |
| 125 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.10349586 |
| 126 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10131157 |
| 127 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09311174 |
| 128 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08194059 |
| 129 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07808201 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07407320 |
| 131 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07267252 |
| 132 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07076101 |
| 133 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07028796 |
| 134 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06698791 |
| 135 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05965955 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05739349 |
| 137 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05174419 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05111269 |
| 139 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04654219 |
| 140 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03181767 |
| 141 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00022422 |
| 142 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99080779 |
| 143 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.98128493 |
| 144 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95298278 |
| 145 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94127591 |
| 146 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92979905 |
| 147 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.92892982 |
| 148 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.92164720 |
| 149 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.91916883 |
| 150 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89789500 |
| 151 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88312265 |
| 152 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87423264 |
| 153 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86702550 |
| 154 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.85810223 |
| 155 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85546818 |
| 156 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.84639625 |
| 157 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84138200 |
| 158 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.82984200 |
| 159 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82189831 |
| 160 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.81499426 |
| 161 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.81054196 |
| 162 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79330585 |
| 163 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.78835831 |
| 164 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78782147 |
| 165 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78686134 |
| 166 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78512328 |
| 167 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.78379853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.62412532 |
| 2 | MP0010094_abnormal_chromosome_stability | 4.46768606 |
| 3 | MP0003693_abnormal_embryo_hatching | 4.13145519 |
| 4 | MP0005410_abnormal_fertilization | 3.62622658 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.47745374 |
| 6 | MP0003077_abnormal_cell_cycle | 3.33614040 |
| 7 | MP0005083_abnormal_biliary_tract | 3.22077035 |
| 8 | MP0008007_abnormal_cellular_replicative | 3.12906794 |
| 9 | MP0005451_abnormal_body_composition | 3.08029020 |
| 10 | MP0009278_abnormal_bone_marrow | 2.96192313 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.91085013 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.79626178 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.77595129 |
| 14 | * MP0008058_abnormal_DNA_repair | 2.67214846 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.66453883 |
| 16 | MP0000537_abnormal_urethra_morphology | 2.61338715 |
| 17 | MP0003303_peritoneal_inflammation | 2.57008898 |
| 18 | MP0002254_reproductive_system_inflammat | 2.32856064 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 2.24169739 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.21332578 |
| 21 | MP0003724_increased_susceptibility_to | 2.16726985 |
| 22 | MP0002419_abnormal_innate_immunity | 2.11754958 |
| 23 | MP0008789_abnormal_olfactory_epithelium | 2.11098220 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 2.07587234 |
| 25 | * MP0001929_abnormal_gametogenesis | 1.99196927 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.96839718 |
| 27 | MP0004858_abnormal_nervous_system | 1.93877733 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.90440560 |
| 29 | MP0001790_abnormal_immune_system | 1.90110928 |
| 30 | MP0005387_immune_system_phenotype | 1.90110928 |
| 31 | MP0001730_embryonic_growth_arrest | 1.88923932 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.83717637 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.82951884 |
| 34 | MP0006292_abnormal_olfactory_placode | 1.80352885 |
| 35 | MP0005408_hypopigmentation | 1.77272906 |
| 36 | MP0008932_abnormal_embryonic_tissue | 1.75173072 |
| 37 | MP0009840_abnormal_foam_cell | 1.73503375 |
| 38 | MP0003186_abnormal_redox_activity | 1.70684178 |
| 39 | MP0001849_ear_inflammation | 1.65126580 |
| 40 | MP0002210_abnormal_sex_determination | 1.61672444 |
| 41 | MP0002160_abnormal_reproductive_system | 1.61249939 |
| 42 | MP0003786_premature_aging | 1.59563859 |
| 43 | MP0005394_taste/olfaction_phenotype | 1.59180529 |
| 44 | MP0005499_abnormal_olfactory_system | 1.59180529 |
| 45 | MP0000350_abnormal_cell_proliferation | 1.54639314 |
| 46 | MP0004510_myositis | 1.53789580 |
| 47 | * MP0003698_abnormal_male_reproductive | 1.53780715 |
| 48 | MP0000313_abnormal_cell_death | 1.53616519 |
| 49 | MP0004233_abnormal_muscle_weight | 1.52599618 |
| 50 | MP0000490_abnormal_crypts_of | 1.51968659 |
| 51 | MP0005377_hearing/vestibular/ear_phenot | 1.50393511 |
| 52 | MP0003878_abnormal_ear_physiology | 1.50393511 |
| 53 | MP0001145_abnormal_male_reproductive | 1.50015209 |
| 54 | MP0003646_muscle_fatigue | 1.47155821 |
| 55 | * MP0002398_abnormal_bone_marrow | 1.44121098 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.43508857 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.42759721 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.39739715 |
| 59 | MP0002132_abnormal_respiratory_system | 1.36180322 |
| 60 | MP0010307_abnormal_tumor_latency | 1.35357278 |
| 61 | MP0003718_maternal_effect | 1.34924451 |
| 62 | MP0001764_abnormal_homeostasis | 1.34427917 |
| 63 | MP0000653_abnormal_sex_gland | 1.33430375 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.32845993 |
| 65 | MP0004147_increased_porphyrin_level | 1.31333365 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.28870522 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.28820115 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.26628508 |
| 69 | MP0003866_abnormal_defecation | 1.22149740 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.21815240 |
| 71 | MP0002722_abnormal_immune_system | 1.20686942 |
| 72 | * MP0002429_abnormal_blood_cell | 1.20601047 |
| 73 | MP0009672_abnormal_birth_weight | 1.19259902 |
| 74 | MP0004947_skin_inflammation | 1.15623764 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.14830025 |
| 76 | MP0005310_abnormal_salivary_gland | 1.14315774 |
| 77 | * MP0000716_abnormal_immune_system | 1.13654964 |
| 78 | MP0001672_abnormal_embryogenesis/_devel | 1.12627815 |
| 79 | MP0005380_embryogenesis_phenotype | 1.12627815 |
| 80 | MP0005671_abnormal_response_to | 1.11911409 |
| 81 | MP0003300_gastrointestinal_ulcer | 1.10188209 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.09702959 |
| 83 | MP0001697_abnormal_embryo_size | 1.09175265 |
| 84 | MP0010386_abnormal_urinary_bladder | 1.08891692 |
| 85 | MP0003183_abnormal_peptide_metabolism | 1.08403158 |
| 86 | MP0002420_abnormal_adaptive_immunity | 1.07639148 |
| 87 | MP0008469_abnormal_protein_level | 1.07427670 |
| 88 | MP0002080_prenatal_lethality | 1.07302637 |
| 89 | MP0003984_embryonic_growth_retardation | 1.06945301 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 1.05496760 |
| 91 | MP0004130_abnormal_muscle_cell | 1.03801980 |
| 92 | MP0001819_abnormal_immune_cell | 1.02805109 |
| 93 | MP0002088_abnormal_embryonic_growth/wei | 1.01448596 |
| 94 | MP0001835_abnormal_antigen_presentation | 0.99489016 |
| 95 | MP0005389_reproductive_system_phenotype | 0.99108607 |
| 96 | * MP0002161_abnormal_fertility/fecundity | 0.98233067 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.97901243 |
| 98 | MP0001800_abnormal_humoral_immune | 0.97030321 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.96437799 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.95101719 |
| 101 | MP0009764_decreased_sensitivity_to | 0.94046547 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.93826450 |
| 103 | MP0001663_abnormal_digestive_system | 0.92961551 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 0.90579778 |
| 105 | MP0000358_abnormal_cell_content/ | 0.90150995 |
| 106 | MP0005397_hematopoietic_system_phenotyp | 0.90022938 |
| 107 | MP0001545_abnormal_hematopoietic_system | 0.90022938 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.89397302 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.88994490 |
| 110 | MP0003436_decreased_susceptibility_to | 0.87470672 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.86238520 |
| 112 | MP0005266_abnormal_metabolism | 0.85728963 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.85060184 |
| 114 | * MP0002405_respiratory_system_inflammati | 0.84227426 |
| 115 | MP0002085_abnormal_embryonic_tissue | 0.82650816 |
| 116 | MP0000678_abnormal_parathyroid_gland | 0.82578407 |
| 117 | MP0002723_abnormal_immune_serum | 0.81625152 |
| 118 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81327974 |
| 119 | MP0000685_abnormal_immune_system | 0.80434488 |
| 120 | MP0002933_joint_inflammation | 0.79987013 |
| 121 | MP0000858_altered_metastatic_potential | 0.79078275 |
| 122 | MP0001119_abnormal_female_reproductive | 0.79034389 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.78523444 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.78505172 |
| 125 | MP0002452_abnormal_antigen_presenting | 0.78209545 |
| 126 | MP0008874_decreased_physiological_sensi | 0.78180493 |
| 127 | MP0000609_abnormal_liver_physiology | 0.76422126 |
| 128 | MP0003705_abnormal_hypodermis_morpholog | 0.75867555 |
| 129 | MP0003879_abnormal_hair_cell | 0.74817449 |
| 130 | MP0000465_gastrointestinal_hemorrhage | 0.73067219 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.72712502 |
| 132 | MP0002735_abnormal_chemical_nociception | 0.72205621 |
| 133 | MP0006082_CNS_inflammation | 0.71947310 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.71577145 |
| 135 | MP0005025_abnormal_response_to | 0.70417269 |
| 136 | MP0005220_abnormal_exocrine_pancreas | 0.69718569 |
| 137 | MP0001873_stomach_inflammation | 0.69239424 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67259984 |
| 139 | MP0002148_abnormal_hypersensitivity_rea | 0.67133671 |
| 140 | MP0008260_abnormal_autophagy | 0.66840624 |
| 141 | MP0003828_pulmonary_edema | 0.66082424 |
| 142 | MP0009785_altered_susceptibility_to | 0.65997953 |
| 143 | MP0001293_anophthalmia | 0.64604226 |
| 144 | MP0000343_altered_response_to | 0.64120770 |
| 145 | MP0001348_abnormal_lacrimal_gland | 0.63956859 |
| 146 | MP0005381_digestive/alimentary_phenotyp | 0.63520999 |
| 147 | MP0000470_abnormal_stomach_morphology | 0.63065306 |
| 148 | MP0003075_altered_response_to | 0.61285504 |
| 149 | MP0005621_abnormal_cell_physiology | 0.61228651 |
| 150 | MP0002086_abnormal_extraembryonic_tissu | 0.61141219 |
| 151 | MP0005174_abnormal_tail_pigmentation | 0.60424305 |
| 152 | MP0000598_abnormal_liver_morphology | 0.58845641 |
| 153 | MP0005000_abnormal_immune_tolerance | 0.58260828 |
| 154 | MP0001845_abnormal_inflammatory_respons | 0.58146642 |
| 155 | MP0003943_abnormal_hepatobiliary_system | 0.58118555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 6.23232640 |
| 2 | Aplastic anemia (HP:0001915) | 5.36192853 |
| 3 | 11 pairs of ribs (HP:0000878) | 4.98223790 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.98103076 |
| 5 | Hypochromic anemia (HP:0001931) | 4.73295372 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.43995972 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.93164601 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.91173238 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.85489490 |
| 10 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.66766413 |
| 11 | Thrombocytosis (HP:0001894) | 3.63305060 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.56961038 |
| 13 | Myositis (HP:0100614) | 3.56297817 |
| 14 | Abnormal number of erythroid precursors (HP:0012131) | 3.54432871 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.42164319 |
| 16 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.36790794 |
| 17 | Pancytopenia (HP:0001876) | 3.34327234 |
| 18 | Cutaneous melanoma (HP:0012056) | 3.29582482 |
| 19 | Abnormality of the anterior horn cell (HP:0006802) | 3.27070720 |
| 20 | Degeneration of anterior horn cells (HP:0002398) | 3.27070720 |
| 21 | Stomatitis (HP:0010280) | 3.25723595 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.22509160 |
| 23 | Prolonged bleeding time (HP:0003010) | 3.21959146 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.20475339 |
| 25 | Microcytic anemia (HP:0001935) | 3.18982263 |
| 26 | Myopathic facies (HP:0002058) | 3.16458453 |
| 27 | Orchitis (HP:0100796) | 3.14059324 |
| 28 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.12745823 |
| 29 | Abnormality of the preputium (HP:0100587) | 3.11877736 |
| 30 | Abnormality of chromosome stability (HP:0003220) | 3.11348088 |
| 31 | Selective tooth agenesis (HP:0001592) | 3.10520423 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.03960404 |
| 33 | Obstructive lung disease (HP:0006536) | 3.03960404 |
| 34 | Oral leukoplakia (HP:0002745) | 3.02088754 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 2.98582341 |
| 36 | Impulsivity (HP:0100710) | 2.98081705 |
| 37 | Bronchitis (HP:0012387) | 2.97009884 |
| 38 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.96859764 |
| 39 | Recurrent fungal infections (HP:0002841) | 2.89000430 |
| 40 | Cellulitis (HP:0100658) | 2.86976808 |
| 41 | Reticulocytopenia (HP:0001896) | 2.84950225 |
| 42 | Reticulocytosis (HP:0001923) | 2.84402083 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.83662152 |
| 44 | Bone marrow hypocellularity (HP:0005528) | 2.82968148 |
| 45 | Colon cancer (HP:0003003) | 2.82835550 |
| 46 | Meckel diverticulum (HP:0002245) | 2.80513602 |
| 47 | Cholelithiasis (HP:0001081) | 2.79449610 |
| 48 | Abnormality of the ileum (HP:0001549) | 2.76698549 |
| 49 | Patellar aplasia (HP:0006443) | 2.75070788 |
| 50 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.74278232 |
| 51 | Nasal polyposis (HP:0100582) | 2.73617569 |
| 52 | Type I transferrin isoform profile (HP:0003642) | 2.72855625 |
| 53 | IgM deficiency (HP:0002850) | 2.63558090 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.62333102 |
| 55 | Abnormality of the fingertips (HP:0001211) | 2.61665015 |
| 56 | Ragged-red muscle fibers (HP:0003200) | 2.60809714 |
| 57 | Absent/shortened dynein arms (HP:0200106) | 2.60181610 |
| 58 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.60181610 |
| 59 | Sloping forehead (HP:0000340) | 2.59444940 |
| 60 | Chronic bronchitis (HP:0004469) | 2.58760971 |
| 61 | Increased IgE level (HP:0003212) | 2.58594611 |
| 62 | Myelodysplasia (HP:0002863) | 2.57702258 |
| 63 | Abnormal protein glycosylation (HP:0012346) | 2.54854350 |
| 64 | Abnormal glycosylation (HP:0012345) | 2.54854350 |
| 65 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.54854350 |
| 66 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.54854350 |
| 67 | Large eyes (HP:0001090) | 2.53433873 |
| 68 | Metaphyseal cupping (HP:0003021) | 2.52785832 |
| 69 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.51943716 |
| 70 | Progressive muscle weakness (HP:0003323) | 2.51122161 |
| 71 | Birth length less than 3rd percentile (HP:0003561) | 2.50009055 |
| 72 | Easy fatigability (HP:0003388) | 2.49400514 |
| 73 | Abnormal hemoglobin (HP:0011902) | 2.49139254 |
| 74 | Abnormality of the thoracic spine (HP:0100711) | 2.49030750 |
| 75 | Colitis (HP:0002583) | 2.48634727 |
| 76 | Urticaria (HP:0001025) | 2.48155496 |
| 77 | Gingivitis (HP:0000230) | 2.45873006 |
| 78 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.45826340 |
| 79 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.45826340 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.45532513 |
| 81 | Recurrent skin infections (HP:0001581) | 2.43580671 |
| 82 | Hypertensive crisis (HP:0100735) | 2.42224152 |
| 83 | Tongue fasciculations (HP:0001308) | 2.37934383 |
| 84 | Clumsiness (HP:0002312) | 2.37410133 |
| 85 | Increased serum ferritin (HP:0003281) | 2.37320801 |
| 86 | Mediastinal lymphadenopathy (HP:0100721) | 2.36238717 |
| 87 | Rhinitis (HP:0012384) | 2.36164939 |
| 88 | Type 2 muscle fiber atrophy (HP:0003554) | 2.35759411 |
| 89 | Reduced antithrombin III activity (HP:0001976) | 2.34565609 |
| 90 | Slow saccadic eye movements (HP:0000514) | 2.34290155 |
| 91 | Encephalitis (HP:0002383) | 2.33992025 |
| 92 | Abnormal gallbladder morphology (HP:0012437) | 2.33688028 |
| 93 | Chromsome breakage (HP:0040012) | 2.32173433 |
| 94 | Cerebral hypomyelination (HP:0006808) | 2.32039790 |
| 95 | Purpura (HP:0000979) | 2.30952678 |
| 96 | Meningitis (HP:0001287) | 2.30630099 |
| 97 | Small intestinal stenosis (HP:0012848) | 2.29443880 |
| 98 | Duodenal stenosis (HP:0100867) | 2.29443880 |
| 99 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.28489770 |
| 100 | Loss of speech (HP:0002371) | 2.27354559 |
| 101 | Rough bone trabeculation (HP:0100670) | 2.25224173 |
| 102 | Poikiloderma (HP:0001029) | 2.24984450 |
| 103 | Progressive external ophthalmoplegia (HP:0000590) | 2.24674483 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 2.24098011 |
| 105 | Cholecystitis (HP:0001082) | 2.24098011 |
| 106 | Diaphragmatic weakness (HP:0009113) | 2.23806958 |
| 107 | Abnormality of the gallbladder (HP:0005264) | 2.23560331 |
| 108 | Retrobulbar optic neuritis (HP:0100654) | 2.23069852 |
| 109 | Optic neuritis (HP:0100653) | 2.23069852 |
| 110 | Pustule (HP:0200039) | 2.22816700 |
| 111 | Limb hypertonia (HP:0002509) | 2.22621327 |
| 112 | Abnormal spermatogenesis (HP:0008669) | 2.21481014 |
| 113 | Missing ribs (HP:0000921) | 2.21136020 |
| 114 | Muscle fiber atrophy (HP:0100295) | 2.20030911 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19648314 |
| 116 | Abnormality of the carotid arteries (HP:0005344) | 2.19190123 |
| 117 | Epistaxis (HP:0000421) | 2.18776680 |
| 118 | Premature graying of hair (HP:0002216) | 2.18717652 |
| 119 | Dysostosis multiplex (HP:0000943) | 2.18435871 |
| 120 | Recurrent cutaneous fungal infections (HP:0011370) | 2.18130721 |
| 121 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.18130721 |
| 122 | Gastrointestinal stroma tumor (HP:0100723) | 2.17522548 |
| 123 | Spontaneous hematomas (HP:0007420) | 2.16758900 |
| 124 | Increased serum lactate (HP:0002151) | 2.16103687 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 2.15977269 |
| 126 | B lymphocytopenia (HP:0010976) | 2.15645508 |
| 127 | Abnormality of B cell number (HP:0010975) | 2.15645508 |
| 128 | Breast hypoplasia (HP:0003187) | 2.15067300 |
| 129 | Thoracic kyphosis (HP:0002942) | 2.14979833 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14071384 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14071384 |
| 132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14071384 |
| 133 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.11215937 |
| 134 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.11215937 |
| 135 | Abnormality of the nasal mucosa (HP:0000433) | 2.10367741 |
| 136 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.10336756 |
| 137 | Recurrent sinusitis (HP:0011108) | 2.09950543 |
| 138 | Abnormality of the columella (HP:0009929) | 2.05028457 |
| 139 | Rectal prolapse (HP:0002035) | 2.04949788 |
| 140 | Rhabdomyolysis (HP:0003201) | 2.03830508 |
| 141 | Lymphoma (HP:0002665) | 2.03038547 |
| 142 | Exercise-induced myalgia (HP:0003738) | 2.02806920 |
| 143 | Abnormality of reticulocytes (HP:0004312) | 2.02719500 |
| 144 | Absent thumb (HP:0009777) | 2.00664526 |
| 145 | Acute hepatic failure (HP:0006554) | 2.00631814 |
| 146 | Microvesicular hepatic steatosis (HP:0001414) | 2.00525346 |
| 147 | Muscle fibrillation (HP:0010546) | 2.00200407 |
| 148 | Chest pain (HP:0100749) | 1.98865878 |
| 149 | Increased IgM level (HP:0003496) | 1.98050423 |
| 150 | Clubbing of toes (HP:0100760) | 1.97487716 |
| 151 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97300742 |
| 152 | Episodic fever (HP:0001954) | 1.96359384 |
| 153 | Bulbar palsy (HP:0001283) | 1.94685388 |
| 154 | Poor head control (HP:0002421) | 1.94490191 |
| 155 | Abnormality of the intervertebral disk (HP:0005108) | 1.91277900 |
| 156 | Bronchiectasis (HP:0002110) | 1.91270062 |
| 157 | Vacuolated lymphocytes (HP:0001922) | 1.90309947 |
| 158 | Hepatic necrosis (HP:0002605) | 1.89435872 |
| 159 | Hyperglycinuria (HP:0003108) | 1.88739094 |
| 160 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87930837 |
| 161 | Carpal bone hypoplasia (HP:0001498) | 1.87754880 |
| 162 | Increased serum pyruvate (HP:0003542) | 1.87552974 |
| 163 | Abnormality of glycolysis (HP:0004366) | 1.87552974 |
| 164 | Fatigue (HP:0012378) | 1.85179334 |
| 165 | Neutropenia (HP:0001875) | 1.84754584 |
| 166 | Lymphopenia (HP:0001888) | 1.83944744 |
| 167 | Hepatocellular necrosis (HP:0001404) | 1.83536546 |
| 168 | Abnormality of T cell physiology (HP:0011840) | 1.82991309 |
| 169 | Leukopenia (HP:0001882) | 1.82595225 |
| 170 | Tracheoesophageal fistula (HP:0002575) | 1.81948040 |
| 171 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81401551 |
| 172 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.80910426 |
| 173 | Petechiae (HP:0000967) | 1.80761192 |
| 174 | Vasculitis (HP:0002633) | 1.79761167 |
| 175 | Broad distal phalanx of finger (HP:0009836) | 1.79650195 |
| 176 | Atelectasis (HP:0100750) | 1.79343470 |
| 177 | Microretrognathia (HP:0000308) | 1.78985188 |
| 178 | Pelvic girdle muscle weakness (HP:0003749) | 1.78740322 |
| 179 | Abnormality of the duodenum (HP:0002246) | 1.77841422 |
| 180 | Pulmonary fibrosis (HP:0002206) | 1.77349293 |
| 181 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.75512550 |
| 182 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75280797 |
| 183 | Neoplasm of the pancreas (HP:0002894) | 1.75106338 |
| 184 | Granulocytopenia (HP:0001913) | 1.74291052 |
| 185 | Severe visual impairment (HP:0001141) | 1.73891210 |
| 186 | Keratitis (HP:0000491) | 1.73451127 |
| 187 | Hemorrhage of the eye (HP:0011885) | 1.73092433 |
| 188 | Hepatosplenomegaly (HP:0001433) | 1.72725214 |
| 189 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.72583385 |
| 190 | Increased CSF lactate (HP:0002490) | 1.72210763 |
| 191 | Toxemia of pregnancy (HP:0100603) | 1.71192933 |
| 192 | Anorexia (HP:0002039) | 1.71011963 |
| 193 | Poikilocytosis (HP:0004447) | 1.70918842 |
| 194 | Abnormal lung lobation (HP:0002101) | 1.67796162 |
| 195 | Abnormality of DNA repair (HP:0003254) | 1.67224537 |
| 196 | Overlapping toe (HP:0001845) | 1.67059425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.38119504 |
| 2 | TRIB3 | 3.49084102 |
| 3 | WEE1 | 3.41785452 |
| 4 | NEK2 | 2.56634626 |
| 5 | TAOK1 | 2.50396865 |
| 6 | TNK2 | 2.50390490 |
| 7 | BRSK1 | 2.43912812 |
| 8 | PNCK | 2.43659637 |
| 9 | CDC7 | 2.36425967 |
| 10 | SMG1 | 2.34868637 |
| 11 | BRSK2 | 2.28542499 |
| 12 | SRPK1 | 2.19157471 |
| 13 | BCKDK | 2.18356945 |
| 14 | PASK | 2.17433980 |
| 15 | TESK1 | 2.16019645 |
| 16 | MAP4K1 | 2.07603718 |
| 17 | SIK1 | 2.06330333 |
| 18 | RIPK4 | 2.06203627 |
| 19 | EEF2K | 2.02099838 |
| 20 | EIF2AK1 | 2.00636397 |
| 21 | MARK2 | 1.96172303 |
| 22 | CDK19 | 1.95437776 |
| 23 | VRK1 | 1.91357392 |
| 24 | NEK1 | 1.90183395 |
| 25 | MAP3K7 | 1.87122862 |
| 26 | PDK3 | 1.85601695 |
| 27 | PDK4 | 1.85601695 |
| 28 | NME2 | 1.85324646 |
| 29 | PRKD2 | 1.76197818 |
| 30 | TTK | 1.73962656 |
| 31 | STK16 | 1.73922550 |
| 32 | ICK | 1.72238441 |
| 33 | TESK2 | 1.64148627 |
| 34 | ATR | 1.61857226 |
| 35 | EPHB1 | 1.57378175 |
| 36 | TSSK6 | 1.55886504 |
| 37 | EIF2AK2 | 1.53163918 |
| 38 | MAP3K3 | 1.48140148 |
| 39 | FLT3 | 1.47160515 |
| 40 | FES | 1.46940158 |
| 41 | MAP2K2 | 1.42065640 |
| 42 | BMX | 1.39117390 |
| 43 | BLK | 1.36335147 |
| 44 | PLK1 | 1.35927765 |
| 45 | SIK2 | 1.35854377 |
| 46 | TAOK3 | 1.35313665 |
| 47 | PLK4 | 1.34139019 |
| 48 | MAP3K13 | 1.33899222 |
| 49 | CCNB1 | 1.32780875 |
| 50 | TYK2 | 1.31594813 |
| 51 | CDK8 | 1.29352582 |
| 52 | PIM2 | 1.28481859 |
| 53 | AURKA | 1.28278109 |
| 54 | CSF1R | 1.28245451 |
| 55 | PRKD3 | 1.26580599 |
| 56 | TEC | 1.25294844 |
| 57 | BTK | 1.24537088 |
| 58 | RPS6KB2 | 1.16754672 |
| 59 | MAP2K3 | 1.15693457 |
| 60 | PTK6 | 1.14465275 |
| 61 | ERN1 | 1.13304709 |
| 62 | DYRK3 | 1.13243630 |
| 63 | TLK1 | 1.12572884 |
| 64 | ZAK | 1.12117498 |
| 65 | TAOK2 | 1.11998117 |
| 66 | MAP3K1 | 1.10917319 |
| 67 | PLK3 | 1.10783839 |
| 68 | TGFBR1 | 1.10696566 |
| 69 | MAP3K14 | 1.10625411 |
| 70 | MAP2K7 | 1.09547843 |
| 71 | CHEK2 | 1.09291624 |
| 72 | IRAK4 | 1.09247021 |
| 73 | CDK7 | 1.05580444 |
| 74 | HCK | 1.02261845 |
| 75 | CAMK1D | 1.01936353 |
| 76 | AURKB | 1.01924760 |
| 77 | IKBKB | 1.01018261 |
| 78 | KIT | 1.00365331 |
| 79 | MARK3 | 1.00219349 |
| 80 | MKNK1 | 0.98448743 |
| 81 | PRPF4B | 0.96386875 |
| 82 | ERBB3 | 0.94165330 |
| 83 | FGR | 0.93665293 |
| 84 | CSK | 0.93615028 |
| 85 | ZAP70 | 0.93559168 |
| 86 | STK10 | 0.91646371 |
| 87 | KDR | 0.91085120 |
| 88 | HIPK2 | 0.90666719 |
| 89 | CHEK1 | 0.88813700 |
| 90 | EIF2AK3 | 0.88534632 |
| 91 | PIM1 | 0.88253175 |
| 92 | PDPK1 | 0.85697505 |
| 93 | MAPK12 | 0.83261966 |
| 94 | MAP3K8 | 0.82523469 |
| 95 | CLK1 | 0.80675823 |
| 96 | STK4 | 0.78026074 |
| 97 | TBK1 | 0.77012483 |
| 98 | BRAF | 0.73570505 |
| 99 | JAK3 | 0.73555599 |
| 100 | IKBKE | 0.73025944 |
| 101 | CDK12 | 0.72735148 |
| 102 | TRPM7 | 0.72180159 |
| 103 | DYRK1B | 0.72118553 |
| 104 | CDK4 | 0.71076260 |
| 105 | MAP3K11 | 0.70833460 |
| 106 | YES1 | 0.69494897 |
| 107 | STK38 | 0.67847571 |
| 108 | MAP3K10 | 0.67461710 |
| 109 | MATK | 0.67142383 |
| 110 | ACVR1B | 0.65437548 |
| 111 | PDK1 | 0.64990009 |
| 112 | RPS6KA4 | 0.64248425 |
| 113 | CAMK4 | 0.64115344 |
| 114 | TXK | 0.63792851 |
| 115 | PKN2 | 0.63724760 |
| 116 | SCYL2 | 0.63353976 |
| 117 | CDC42BPA | 0.61343785 |
| 118 | PDK2 | 0.61138986 |
| 119 | LYN | 0.60563358 |
| 120 | MAP2K6 | 0.60264459 |
| 121 | MAPKAPK3 | 0.59560451 |
| 122 | RPS6KL1 | 0.59124179 |
| 123 | RPS6KC1 | 0.59124179 |
| 124 | KSR2 | 0.58319735 |
| 125 | MAPKAPK5 | 0.58169474 |
| 126 | STK11 | 0.57892504 |
| 127 | RPS6KA6 | 0.57386022 |
| 128 | PTK2B | 0.57024505 |
| 129 | LRRK2 | 0.56926331 |
| 130 | SGK3 | 0.54661705 |
| 131 | MTOR | 0.53775756 |
| 132 | PAK4 | 0.52482617 |
| 133 | TTN | 0.52150167 |
| 134 | GRK6 | 0.51851786 |
| 135 | MAP3K4 | 0.51722301 |
| 136 | MAPKAPK2 | 0.50612846 |
| 137 | SIK3 | 0.50335265 |
| 138 | CSNK2A1 | 0.50043910 |
| 139 | ATM | 0.49226661 |
| 140 | RPS6KA1 | 0.49186525 |
| 141 | FGFR4 | 0.48759241 |
| 142 | MAPK7 | 0.48481173 |
| 143 | * CDK2 | 0.48432439 |
| 144 | RAF1 | 0.48422266 |
| 145 | PRKAA2 | 0.48055459 |
| 146 | RPS6KA2 | 0.45963232 |
| 147 | NME1 | 0.44477017 |
| 148 | PAK1 | 0.44320125 |
| 149 | CAMK1G | 0.44011058 |
| 150 | VRK2 | 0.43671002 |
| 151 | IRAK3 | 0.43228541 |
| 152 | SYK | 0.42859448 |
| 153 | CSNK2A2 | 0.42171521 |
| 154 | DYRK2 | 0.40612466 |
| 155 | CAMKK1 | 0.40490579 |
| 156 | CAMK1 | 0.39592560 |
| 157 | RPS6KA5 | 0.39472040 |
| 158 | LCK | 0.39383586 |
| 159 | MAPK11 | 0.38857513 |
| 160 | BMPR2 | 0.37146976 |
| 161 | RPS6KB1 | 0.35938570 |
| 162 | IRAK2 | 0.35161113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.32054682 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.87316194 |
| 3 | * Base excision repair_Homo sapiens_hsa03410 | 3.33960271 |
| 4 | Homologous recombination_Homo sapiens_hsa03440 | 2.86021964 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.85847467 |
| 6 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.83623643 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.74317241 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.66611899 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.63932682 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.61290582 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.61114686 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.59547261 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.37787412 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36483842 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.25995171 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.22199818 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14002573 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.97680984 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.82491194 |
| 20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.82025782 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.78208400 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74335645 |
| 23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71512508 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69467692 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67812469 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66524405 |
| 27 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.62947426 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57972526 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.53287051 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.51951953 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.50308555 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.49382652 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.47426942 |
| 34 | Protein export_Homo sapiens_hsa03060 | 1.46406227 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.43092433 |
| 36 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.40861303 |
| 37 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.39909591 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.38402703 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.38301589 |
| 40 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.37662088 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.36743538 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.34885239 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.34313844 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28834246 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.28334188 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.27261182 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25520240 |
| 48 | Malaria_Homo sapiens_hsa05144 | 1.22115106 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19949890 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19052678 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18328258 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14073933 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12558858 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11550474 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10844598 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.10707505 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10393044 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08782493 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07998849 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.07583050 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07038639 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06759445 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 1.04400473 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01352437 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.01240365 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 1.00743956 |
| 67 | * Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99808933 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.99363521 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98935973 |
| 70 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.97877951 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97875378 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96053111 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.95114418 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93603766 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92121542 |
| 76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.92091316 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91653761 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91613209 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91044016 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.90580520 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90388177 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88527249 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88057139 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87714631 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.83585084 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83339511 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81798842 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81331945 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.80330788 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80142541 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78320170 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78264429 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76764534 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72285314 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71890120 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71500027 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70998113 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70584516 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.70179435 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69824767 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69285696 |
| 102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69079316 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.66778198 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65916409 |
| 105 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65606436 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65199232 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64827126 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63219015 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60818688 |
| 110 | Allograft rejection_Homo sapiens_hsa05330 | 0.60068619 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59582331 |
| 112 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57734868 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56873190 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56481934 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56052386 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56017523 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54769712 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.52105501 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52018073 |
| 120 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50583546 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49977964 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48998776 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48949172 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48811265 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48406314 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48249461 |
| 127 | Measles_Homo sapiens_hsa05162 | 0.48043501 |
| 128 | Shigellosis_Homo sapiens_hsa05131 | 0.46966589 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46895493 |
| 130 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45462561 |
| 131 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42596700 |
| 132 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42043228 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41082620 |
| 134 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39236643 |
| 135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38461273 |
| 136 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38205726 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38196695 |
| 138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37580203 |
| 139 | Prostate cancer_Homo sapiens_hsa05215 | 0.36903970 |
| 140 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36863634 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35980392 |
| 142 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35210930 |
| 143 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33594808 |
| 144 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33218106 |
| 145 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33079375 |
| 146 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32973627 |
| 147 | Influenza A_Homo sapiens_hsa05164 | 0.32526861 |
| 148 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32320719 |
| 149 | Peroxisome_Homo sapiens_hsa04146 | 0.31293192 |
| 150 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30935431 |
| 151 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30769805 |
| 152 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29346775 |
| 153 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28876677 |
| 154 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28511141 |
| 155 | Apoptosis_Homo sapiens_hsa04210 | 0.27878507 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25783931 |
| 157 | Hepatitis B_Homo sapiens_hsa05161 | 0.25710594 |
| 158 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25388289 |
| 159 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24448406 |
| 160 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.21825849 |
| 161 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20344024 |
| 162 | Thyroid cancer_Homo sapiens_hsa05216 | 0.19106535 |
| 163 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.19013917 |
| 164 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.18660130 |
| 165 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18602058 |
| 166 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.18474097 |
| 167 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.17838234 |
| 168 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.17255166 |

